◼ Archived
Health
Novel Injectable Drug Cuts Visceral Fat in Phase 2 Trial
A novel injectable drug called CBL-514 is drawing attention for reducing visceral fat and targeting fat cells without Ozempic or surgery.
5 trends tracked about this subject — the full history, oldest to newest below.
A novel injectable drug called CBL-514 is drawing attention for reducing visceral fat and targeting fat cells without Ozempic or surgery.
Pulitzer winner Hernan Diaz returns with a new book, sparking intense critical debate across major cultural outlets.
The prestigious Prix Goncourt has removed a Canadian-Haitian writer from its prize list following accusations that AI was used to write his debut novel.
6 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
MrBeast and James Patterson's new novel faces a troubling debut amid conflicting reports on reader demand and sales.